Jing Zhang

Professor, Medical Research Institute



Jing Zhang, PhD

2010-2013  Ph.D  Cell Biology and Innate Immunity  Wuhan University, P.R. China

2008-2010   M.S   Cell Biology and Innate Immunity  Wuhan University, P.R. China

2004-2008  B.S  Life Science  Xiamen University, P.R. China

Professional experience

2019-          Professor     Medical Research Institute, Wuhan University, P.R. China

2017-2019  Research Assistant Professor,  Pathology& Lab Medicine,    

                                                                       Lineberger Comprehensive Cancer Center

                                                                       The University of North Carolina at Chapel Hill

2013-2017 Postdoc Research Associate      Lineberger Comprehensive Cancer Center,

                                                                        University of North Carolina at Chapel

Honors and awards

2016          DoD Breast Cancer Research Program Breakthrough Fellowship

2015          UCRF Pilot Award

2013          Academic Innovation Award for Graduate Students, Ministry of Education of China

2012          National Scholarship for Graduate Students, Ministry of Education of China

Research Areas

Our research interests involve the study of mechanisms of key signaling transduction pathways and

how alterations in gene expression, post-translational modification or cell metabolism contribute to cancers.

Selected Publications

1. Zhang J*, Wu T*, Simon J, Takada M, Saito R, Fan C, Liu XD, Jonasch E, Xie L, Chen X, Yao X, Teh BT, Tan P, Zheng X, Li M, Lawrence C, Fan J, Geng J, Liu X, Hu L, Wang J, Liao C, Hong K, Zurlo G, Parker JS, Auman JT, Perou CM, Rathmell WK, Kim WY, Kirschner MW, Kaelin WG Jr, Baldwin AS, Zhang Q. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018 Jul 20;361(6399):290-295. doi: 10.1126/science.aap8411. PubMed PMID: 30026228.

  •  Highlighted by Sanchez DJ and Simon MC. Transcriptional control of kidney cancer. Science 2018 Jul 20; 361 (6399): 226-227. DOI: 10.1126/science.aau4385

  •  Commentary: ZHX2 is an oncogenic driver of kidney cancer. Cancer Discovery 2018 Jul 27 DOI: 10.1158/2159-8290.CD-RW2018-125

2. Zhang J#, Zhang Q#. VHL and Hypoxia Signaling: Beyond HIF in Cancer. Biomedicines. 2018 Mar 19;6(1). pii: E35. doi: 10.3390/biomedicines6010035. Review. PubMed PMID: 29562667; PubMed Central PMCID: PMC5874692.

3. Zhang J*, Wang C*, Chen X, Takada M, Fan C, Zheng X, Wen H, Liu Y, Wang CG, Pestell RG, Kaelin WG Jr, Liu XS and Zhang Q (2015). EglN2 Associates with NRF-PGC1α Complex and Controls Mitochondrial Function in Breast Cancer. EMBO J, 2015 Dec 2; 34(23): 2953-70,

4. Zhang J, Zheng X and Zhang Q. EglN2 positively regulates mitochondrial function in breast cancer. Mol Cell Oncol, 2015 Dec 22;3(2):e1120845. doi: 10.1080/23723556.2015.1120845. eCollection 2016 Mar. PubMed PMC4905419.

5. Zhang J, Hu MM, Shu HB, Li S. Death-associated protein kinase 1 is an IRF3/7-interacting protein that is involved in the cellular antiviral immune response. Cell Mol Immunol. 2014 May;11(3):245-52. PubMed PMID: 24531619; PubMed Central PMCID: PMC4085485.

6. Zhang J, Hu MM, Wang YY, Shu HB. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J Biol Chem. 2012 Aug 17;287(34):28646-55. PubMed PMID: 22745133; PubMed Central PMCID: PMC3436586.

7. Ran Y, Zhang J, Liu LL, Pan ZY, Nie Y, Zhang HY, Wang YY. Autoubiquitination of TRIM26 links TBK1 to NEMO in RLR-mediated innate antiviral immune response. J Mol Cell Biol. 2016 Feb;8(1):31-43. PubMed PMID: 26611359.

8. Hu MM, Yang Q, Zhang J, Liu SM, Zhang Y, Lin H, Huang ZF, Wang YY, Zhang XD, Zhong B, Shu HB. TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3. Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1509-14. PubMed PMID: 24434549; PubMed Central PMCID: PMC3910612.

9. Chen H, Li Y, Zhang J, Ran Y, Wei J, Yang Y, Shu HB. RAVER1 is a coactivator of MDA5-mediated cellular antiviral response. J Mol Cell Biol. 2013 Apr;5(2):111-9. PubMed PMID: 23390309.

10. Lei CQ, Zhong B, Zhang Y, Zhang J, Wang S, Shu HB. Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity. 2010 Dec 14;33(6):878-89. PubMed PMID: 21145761.

Tel: 0086-27-68750205 Fax: 0086-27-68759675  Email:

Contact address: Donghu Road, No. 115, Wuchang District, Wuhan, Hubei Province, P.R. China. 430071

Copyright @ 2016 Medical Research Institute